Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 27,758 shares at $398.71 ($11.1M) on 2020-02-13, disclosed to the SEC on 2020-02-14.
Open-market sale of $11.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $398.71 | 637 | $254K | 2.3% |
| 2 | $398.71 | 637 | $254K | 2.3% |
| 3 | $399.41 | 800 | $320K | 2.9% |
| 4 | $400.03 | 5,000 | $2.0M | 18.0% |
| 5 | $400.03 | 5,000 | $2.0M | 18.0% |
| 6 | $400.16 | 7,842 |
| $3.1M |
| 28.3% |
| 7 | $400.16 | 7,842 | $3.1M | 28.3% |
| Total | $400.03 avg | 27,758 | $11.1M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |